Mark Sabag - 04 Mar 2025 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role
Executive Vice President, International Markets Commercial
Signature
/s/ Dov Bergwerk as attorney-in-fact for Mark Sabag
Issuer symbol
TEVA
Transactions as of
04 Mar 2025
Net transactions value
$0
Form type
4
Filing time
06 Mar 2025, 16:08:35 UTC
Previous filing
05 Mar 2025
Next filing
07 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TEVA Ordinary Shares Options Exercise +33,512 +15% 263,376 04 Mar 2025 Direct F1, F2
transaction TEVA Ordinary Shares Options Exercise +18,601 +7.1% 281,977 04 Mar 2025 Direct F1, F2
transaction TEVA Ordinary Shares Options Exercise +183,169 +65% 465,146 04 Mar 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TEVA Restricted Share Units Options Exercise $0 -33,512 -50% $0.000000 33,512 04 Mar 2025 Ordinary Shares 33,512 Direct F1, F2, F3
transaction TEVA Restricted Share Units Options Exercise $0 -18,601 -25% $0.000000 55,803 04 Mar 2025 Ordinary Shares 18,601 Direct F1, F2, F4
transaction TEVA Restricted Share Units Options Exercise $0 -183,169 -100% $0.000000 0 04 Mar 2025 Ordinary Shares 183,169 Direct F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2 Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3 Restricted share units were granted on March 4, 2022, with 33,512 vested on each of March 4, 2023, March 4, 2024 and March 4, 2025, and 33,512 vesting on March 4, 2026.
F4 Restricted share units were granted on March 4, 2024, with 18,601 vested on March 4, 2025, and 18,601 vesting on each of March 4, 2026, March 4, 2027 and March 4, 2028.
F5 Restricted share units were granted on January 28, 2025 pursuant to the satisfaction of performance criteria and vested on March 4, 2025.

Remarks:

Executive Vice President, International Markets Commercial